...The companies formed Phytogen Seed Company LLC, a joint venture that will market and develop new... ...in return for a 51 percent interest in Phytogen Seed. Boswell will contribute its existing Phytogen...
...DRI invested C$3 million (US$2.16 million) in Phytogen, bringing DRI's total investment in the company to... ...bringing DRI's total investment in the company to C$4.5 million. DRI receives increased royalties on Phytogen's... ...the time of an IPO. The deal is part of a C$7 million investment in Phytogen...
LXR received four U.S. patents and a notice of allowance for a U.S. patent covering its apoptotic compounds. Patent No. 5,567,425 covers methods of preventing apoptosis in cells using plant-derived inhibitors. Patent No. 5,620,888 covers...
...Phytogen’s Phytogen International LLC subsidiary granted Mylan’s Mylan Pharmaceutical division an exclusive license to sell generic... ...division an exclusive license to sell generic taxol (paclitaxel) in the U.S., Canada and Mexico. Phytogen... ...million (US$1.1 million) to Phytogen in exchange for an undisclosed percentage of revenues from paclitaxel. Phytogen Life Sciences Inc....
...The companies formed Phytogen Seed Company LLC, a joint venture that will market and develop new... ...in return for a 51 percent interest in Phytogen Seed. Boswell will contribute its existing Phytogen...
...DRI invested C$3 million (US$2.16 million) in Phytogen, bringing DRI's total investment in the company to... ...bringing DRI's total investment in the company to C$4.5 million. DRI receives increased royalties on Phytogen's... ...the time of an IPO. The deal is part of a C$7 million investment in Phytogen...
LXR received four U.S. patents and a notice of allowance for a U.S. patent covering its apoptotic compounds. Patent No. 5,567,425 covers methods of preventing apoptosis in cells using plant-derived inhibitors. Patent No. 5,620,888 covers...
...Phytogen’s Phytogen International LLC subsidiary granted Mylan’s Mylan Pharmaceutical division an exclusive license to sell generic... ...division an exclusive license to sell generic taxol (paclitaxel) in the U.S., Canada and Mexico. Phytogen... ...million (US$1.1 million) to Phytogen in exchange for an undisclosed percentage of revenues from paclitaxel. Phytogen Life Sciences Inc....